Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.66 USD | +1.23% | +3.73% | +4.93% |
May. 08 | Syndax Pharmaceuticals Q1 Net Loss Widens | MT |
May. 08 | Transcript : Syndax Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.93% | 1.9B | |
+25.97% | 46.71B | |
+48.83% | 41.8B | |
-1.04% | 41.52B | |
-3.42% | 29.55B | |
+10.26% | 25.78B | |
-20.74% | 19.26B | |
+0.65% | 12.14B | |
-0.88% | 12.08B | |
+26.70% | 11.98B |
- Stock Market
- Equities
- SNDX Stock
- News Syndax Pharmaceuticals, Inc.
- Citigroup Adjusts Price Target on Syndax Pharmaceuticals to $31 From $32, Keeps Buy Rating